"Drug company Shire rose 1.5 per cent to £10.15 on talk of a £14 a share bid approach from a US rival. However, traders were quick to point out that David Mott, a non- executive director, declared the purchase of 15,000 shares on Tuesday, something he would not have been able to do had the company received a bid."
http://www.ft.com/cms/s/0/0c252f24-e440-11dc-a495-0000779fd2ac.html
Wednesday, February 27, 2008
SHP
